CFA
SAGE

CT Financial Advisors’s Sage Therapeutics SAGE Stock Holding History

CT Financial Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.21K Hold
17
– – ﹤0.01% 576
2016
Q4 		$868 Hold
17
– – ﹤0.01% 590
2016
Q3 		$783 Hold
17
– – ﹤0.01% 592
2016
Q2 		$512 Hold
17
– – ﹤0.01% 611
2016
Q1 		$546 Hold
17
– – ﹤0.01% 600
2015
Q4 		$991 Buy
+17
New +$842 ﹤0.01% 585

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

CT Financial Advisors's SAGE Position: Q1 2017 in Review

CT Financial Advisors held its Sage Therapeutics (SAGE) position steady in Q1 2017 at 17 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

CT Financial Advisors first reported a position in SAGE in Q4 2015 and has held it in 6 quarters since. 189 funds tracked by Wall St. Rank hold SAGE as of Q1 2017.

  • CT Financial Advisors held 17 shares of Sage Therapeutics worth $1.21K as of Q1 2017.
  • CT Financial Advisors left its Sage Therapeutics share count unchanged in Q1 2017.
  • Sage Therapeutics made up ﹤0.01% of CT Financial Advisors's portfolio in Q1 2017, its #576 holding.
  • CT Financial Advisors first reported a position in Sage Therapeutics in Q4 2015 and has held it in 6 quarters since.
  • 189 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.